Ceredase (Genzyme) en es it fr

Ceredase (Genzyme) Brand names, Ceredase (Genzyme) Analogs

Ceredase (Genzyme) Brand Names Mixture

  • No information avaliable

Ceredase (Genzyme) Chemical_Formula


Ceredase (Genzyme) RX_link


Ceredase (Genzyme) fda sheet

Ceredase (Genzyme) msds (material safety sheet)

Ceredase (Genzyme) Synthesis Reference

No information avaliable

Ceredase (Genzyme) Molecular Weight


Ceredase (Genzyme) Melting Point

No information avaliable

Ceredase (Genzyme) H2O Solubility

No information avaliable

Ceredase (Genzyme) State


Ceredase (Genzyme) LogP


Ceredase (Genzyme) Dosage Forms

Powder for solution; Solution (IV injection)

Ceredase (Genzyme) Indication

For the treatment of Gaucher's disease (deficiency in glucocerebrosidase)

Ceredase (Genzyme) Pharmacology

Gaucher disease is characterized by a functional deficiency in Beta-glucocerebrosidase enzymatic activity and the resultant accumulation of lipid glucocerebroside in tissue macrophages which become engorged and are termed Gaucher cells. Gaucher cells are typically found in liver, spleen and bone marrow. This can lead to an enlarged spleen and liver (hepatosplenomegaly). Secondary hematologic sequelae include severe anemia and thrombocytopenia. Injections of imiglucerase into Gaucher disease patients leads to elevated serum levels of the enzyme and reduction in the accumulation of glucocerebroside leading to reduced anemia and thrombocytopenia, reduced spleen and liver size, and decreased cachexia

Ceredase (Genzyme) Absorption

No information avaliable

Ceredase (Genzyme) side effects and Toxicity

No information avaliable

Ceredase (Genzyme) Patient Information

No information avaliable

Ceredase (Genzyme) Organisms Affected

Humans and other mammals